When a patient sits down in my chair and pulls up a hat or pulls back their hair to show me a part line that has widened over the last two years, the conversation that follows is one I take seriously. Hair loss is not cosmetic in the dismissive sense of that word. I see it pull confidence out of intelligent, accomplished people who have otherwise figured out how to handle every other curveball middle age has thrown them. By the time someone books a scalp consultation, they have usually already tried minoxidil, biotin gummies, three different shampoos with caffeine in them, and at least one supplement that promised results in 30 days. None of it worked the way the marketing said it would, and they want to know if there is something real that does.
The DE|RIVE protocol is what I built our hair restoration program around because the underlying technology — exosome therapy paired with controlled scalp microneedling — addresses follicle biology directly rather than trying to slow the loss with topical drugs that work on roughly half of the people who use them. But the protocol is only as good as the workup that precedes it. I want to walk through both.
What exosomes actually do at the follicle
Exosomes are extracellular vesicles, roughly 30 to 150 nanometers across, that cells release as a way of signaling to other cells. They carry cargo — growth factors, signaling proteins, microRNAs — that influence the behavior of the recipient cell. The EXO|E exosomes we use in DE|RIVE hair restoration are derived from human-derived stem cells and concentrated specifically for the growth factor profile that matters at the hair follicle: VEGF, FGF, KGF, IGF-1, and a panel of others involved in dermal papilla signaling.
The dermal papilla is the small cluster of cells at the base of each follicle that controls the hair growth cycle. When the dermal papilla receives the right growth factor signaling, the follicle stays in anagen — the active growth phase — longer, produces a thicker hair shaft, and resists the miniaturization that drives androgenetic patterns. When that signaling weakens with age, hormonal shifts, inflammation, or DHT pressure, the dermal papilla effectively goes quiet. The follicle moves into telogen sooner, the hair shaft thins, and over years the follicle miniaturizes to the point of producing only fine vellus hair.
Exosomes deliver that signaling cargo directly into the perifollicular tissue. The microneedling component matters because it accomplishes two things simultaneously: it creates microchannels that let the exosome solution penetrate to the depth where the follicle bulb actually lives (about 3 to 4 mm), and the controlled micro-injury triggers the body's own wound healing cascade — which itself produces growth factors and recruits stem cells to the treated area. The two mechanisms compound. This is why microneedling alone produces some response, exosomes alone produce some response, and the two together produce meaningfully more than either in isolation.
What I look for at the first scalp evaluation
Before I commit a patient to the DE|RIVE protocol, I want to know what kind of hair loss I am actually treating. The protocol is highly effective for some patterns and a poor fit for others.
Pattern of loss. I look at the part line, the temples, the crown, and the nape. Diffuse thinning across the top with preservation of the back and sides points toward androgenetic alopecia — the most common pattern and the one DE|RIVE addresses best. Patchy, well-circumscribed bald spots point toward alopecia areata, which is autoimmune and needs a different approach. Loss with visible scarring, redness, or follicular plugging points toward cicatricial alopecia — and regenerative treatment on a scarred scalp is wasted treatment because the follicles are gone, not dormant.
Pull test. I grasp a small bundle of hairs near the root and apply gentle traction. If more than five or six hairs come out with each pull across multiple sites, the patient is in active telogen effluvium — usually triggered by a stressor 2 to 4 months prior. That changes the conversation. Telogen effluvium recovers on its own once the trigger is removed. DE|RIVE can accelerate it, but it is not what determines the outcome.
Hair shaft characteristics. Miniaturization — fine vellus-like hairs interspersed with terminal hairs — is the visual hallmark of androgenetic loss. I want to see whether miniaturization is present and how widely distributed it is.
Lab panel. This is the piece most patients have not had done. I order ferritin (target above 70 for active hair growth, not just above the lab's reference floor of 15), TSH with free T3 and free T4 and reverse T3, vitamin D (target above 50), zinc, B12, and a sex hormone panel. For women in their 40s and 50s I add a full perimenopause workup. For men, total and free testosterone, SHBG, and DHT. I see undiagnosed iron deficiency in women and undiagnosed thyroid dysfunction in both sexes drive a meaningful percentage of the hair loss patterns walking into our clinic. Treating the scalp without correcting the underlying nutritional or hormonal driver produces disappointing results that are predictable from the labs.
What a session actually looks like and how the series is built
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
A DE|RIVE session at our Columbus consultation location or in Warner Robins runs about 60 to 75 minutes start to finish. I cleanse the scalp, apply topical numbing for 20 to 30 minutes if the patient wants it, and then perform controlled microneedling across the affected zones at a depth calibrated to the scalp tissue thickness — usually 1.5 to 2.5 mm depending on the area. The exosome solution is applied during and immediately after the microneedling so the channels are still open and the cargo reaches the perifollicular tissue.
Most patients describe the procedure as well-tolerated with the topical. Without the topical, it is uncomfortable but not severe — closer to a vibrating buzz than a sharp pain. The scalp is pink for 24 to 48 hours and may feel warm or mildly tender. I tell patients to skip the gym for a day, skip the sauna, leave the scalp alone, and wash with a gentle shampoo the next morning.
The standard initial series is 3 to 4 sessions spaced 4 to 6 weeks apart. I space them around the hair growth cycle deliberately — pushing growth factor signaling at the points where the follicle is most receptive. After the initial series, maintenance runs every 4 to 6 months indefinitely. This is the part patients sometimes resist hearing: the underlying biology that drove the original thinning has not gone anywhere. We are pushing back against it. Stop pushing, and the system reverts toward where it was headed.
Where DE|RIVE sits relative to PRP, transplant, and the medication options
Patients often ask me how DE|RIVE compares to vampire facial PRP protocols adapted for the scalp. PRP works on the same general principle — concentrated growth factors delivered into the perifollicular tissue — but the growth factor concentration in patient-derived PRP varies significantly with the patient's platelet count, hematocrit, age, and the specific spin protocol used. A 35-year-old healthy patient produces high-quality PRP. A 60-year-old with chronic inflammation produces less robust PRP. Exosomes are standardized — the same growth factor cargo is delivered at the same concentration to every patient.
PRP is still a reasonable option for patients who want an autologous product or who are price-sensitive. I do not believe it produces equivalent results to exosomes in the average patient, but it is not nothing.
Surgical transplant is a different category entirely. Transplant is the right answer for patients with established, dense hair loss in defined zones — usually advanced androgenetic patterns where regenerative treatment alone will not restore what has already been lost. DE|RIVE complements transplant well: I have patients who had a transplant five years ago and use DE|RIVE to preserve the surrounding native hair while extending the visual result of the transplanted grafts. But I do not pretend exosomes will rebuild a fully bald crown. They will not.
Topical and oral pharmacotherapy — minoxidil, finasteride, dutasteride, oral minoxidil — work alongside the regenerative approach when appropriate. I evaluate each one against the individual picture rather than reflexively prescribing.
Why hormone status changes everything
For my mid-life patients, the conversation about hormone therapy for women and men's hormone therapy for men is part of the hair conversation whether the patient came in expecting it or not. Estrogen supports anagen duration. Progesterone modulates the 5-alpha-reductase enzyme that converts testosterone to DHT. Thyroid drives hair shaft production directly. Testosterone in women — yes, women produce and need testosterone — supports follicle vitality at appropriate physiological levels.
Patients I treat for perimenopausal hair shedding while ignoring their hormone picture get a fraction of the response patients get when we address both. The opposite is also true: patients who optimize hormones but never address the scalp directly often see their density stabilize without the regrowth that DE|RIVE produces. The two work together.
The clinical next step
If you have been losing hair for more than three months and the loss is interfering with how you feel about how you look, do not keep waiting to see if it stops on its own. The earlier we intervene, the more native follicles we have to work with. Book a scalp consultation and bring any recent lab work you have, plus a list of every supplement and medication you are currently taking. I will do a structured scalp exam, order whatever labs are missing, and tell you honestly whether DE|RIVE is the right tool for what is happening on your head — or whether something else is. Either answer is a useful one.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.